Zobrazeno 1 - 10
of 190
pro vyhledávání: '"heparin prophylaxis"'
Publikováno v:
Акушерство, гинекология и репродукция, Vol 12, Iss 2, Pp 21-31 (2018)
The aim of the study was to determine the efficacy of heparin prophylaxis in preventing pregnancy complications in patients with the manifested laboratory phenotype – resistance to activated protein C (APC-resistance with NR ≤ 0.49) Factor V Leid
Externí odkaz:
https://doaj.org/article/5d4f4045fad94557b995ed46aa1c0b8a
Autor:
A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova
Publikováno v:
Фармакоэкономика, Vol 6, Iss 3, Pp 27-30 (2015)
To solve the problem of infertility in the world assisted reproductive technologies (ART) are widely used, which relate to the financial and expensive high-tech medical care. This paper shows that the conduction of therapeutic correction of excessive
Externí odkaz:
https://doaj.org/article/ab36e7610e9444cc96728eae6d7e8b2a
Autor:
Ahmed Negida, Eshak I. Bahbah, Amr Menshawy, Gehad El Ashal, Mohamed Abdel-Maboud, Ahmed Elgebaly
Publikováno v:
Journal of Thrombosis and Thrombolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba2349cc1fcb8c837a65cf1607c7cfd
https://doi.org/10.1007/s11239-020-02253-x
https://doi.org/10.1007/s11239-020-02253-x
Autor:
Alexander M. Friedman, Mary E. D'Alton
Publikováno v:
American journal of obstetrics and gynecology. 225(3)
Venous thromboembolism represents a persistent proportionate cause of maternal mortality in the United States accounting for 9% to 10% of maternal deaths. Given that overall maternal mortality rose >40% since the late 1990s, it is likely that absolut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e757543bcd94f2a17fc48abbae6167
https://pubmed.ncbi.nlm.nih.gov/33974905
https://pubmed.ncbi.nlm.nih.gov/33974905
Publikováno v:
Акушерство, гинекология и репродукция, Vol 12, Iss 2, Pp 21-31 (2018)
The aim of the study was to determine the efficacy of heparin prophylaxis in preventing pregnancy complications in patients with the manifested laboratory phenotype – resistance to activated protein C (APC-resistance with NR ≤ 0.49) Factor V Leid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1319ce5e88f96bf4103bde070a318cc6
https://www.gynecology.su/jour/article/view/491
https://www.gynecology.su/jour/article/view/491
Publikováno v:
Phlebologie. 46:271-275
SummaryAim: The purpose of this article is to underline complications in venous surgery during the past 30 years and new ones arising with the introduction of technologies. We also discuss the “natural reduction” of some of these and how to preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::549d1fab41861a35952c7e9e9a247988
https://doi.org/10.12687/phleb2383-5-2017
https://doi.org/10.12687/phleb2383-5-2017
Autor:
Dugalic, Stefan, Petronijevic, Milos, Stefanovic, Aleksandar, Stefanovic, Katarina, Petronijevic, Svetlana Vrzic, Stanisavljevic, Dejana, Kepeci, Sonja Perkovic, Milincic, Nemanja, Pantic, Igor, Perovic, Milan
Publikováno v:
Medicine
Previous adverse pregnancy outcomes (APO) in women with hereditary thrombophilia have emerged as new indications for prophylactic use of low-molecular-weight heparin (LMWH) during pregnancy. Recent meta-analysis conducted to establish if LMWH may pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95db2555a772a3d38c4a17b31755da21
http://europepmc.org/articles/PMC6716684
http://europepmc.org/articles/PMC6716684
Publikováno v:
Science meets clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8fe0b5a20ce81948d9b5ba9419105fd
https://doi.org/10.1055/s-0039-1680275
https://doi.org/10.1055/s-0039-1680275
Publikováno v:
Journal of Neuroanaesthesiology and Critical Care, Vol 03, Iss 03, Pp 245-248 (2016)
Unfractionated heparin is a widely used drug to prevent deep vein thrombosis and pulmonary emboli in patients at risk. With the advent of newer anticoagulants having lesser side effects, its use has diminished but not out of service. Here, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f206417738c7c4b376be2f90751d328
https://doi.org/10.4103/2348-0548.190071
https://doi.org/10.4103/2348-0548.190071
Autor:
André Zonetti de Arruda Leite, Matheus Azevedo, Aytan Miranda Sipahi, Adriana Ribas Andrade, Aderson Omar Mourão Cintra Damião, Alexandre Carlos, Luísa Leite Barros
Publikováno v:
Clinical and Translational Gastroenterology
Objectives Patients with inflammatory bowel disease have a higher risk of thrombosis, which is associated with a higher morbidity and mortality. Most data about VTE are related to hospitalized patients with active disease, but several cases happen in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054d6b6b2bd0752e0c113843675fc622
http://europepmc.org/articles/PMC5886983
http://europepmc.org/articles/PMC5886983